Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease.
Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Liu, C; Fei, L; El-Khider, F; Dasarathy, S; Xanthakos, SA; Mouzaki, M.
European Journal of Clinical Nutrition.
2020;
74:427-435.
Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity.
Orkin, S; Brokamp, C; Yodoshi, T; Trout, AT; Liu, C; Meryum, S; Taylor, S; Wolfe, C; Sheridan, R; Seth, A; et al.
Journal of Pediatric Gastroenterology and Nutrition.
2020;
70:364-370.
Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.
Seth, A; Orkin, S; Yodoshi, T; Liu, C; Fei, L; Hardy, J; Trout, AT; Arce Clachar, A; Bramlage, K; Xanthakos, S; et al.
Pediatric Obesity.
2020;
15.
Nutrition Support of Children with Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Mouzaki, M; Bronsky, J; Gupte, G; Hojsak, I; Jahnel, J; Pai, N; Quiros-Tejeira, RE; Wieman, R; Sundaram, S.
Journal of Pediatric Gastroenterology and Nutrition.
2019;
69:498-511.
Relationship between abdominal fat stores and liver fat, pancreatic fat, and metabolic comorbidities in a pediatric population with non-alcoholic fatty liver disease.
Trout, AT; Hunte, DE; Mouzaki, M; Xanthakos, SA; Su, W; Zhang, B; Dillman, JR.
Abdominal Radiology.
2019;
44:3107-3114.
Psychotropic Medications Are Associated with Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.
Mouzaki, M; Yodoshi, T; Arce-Clachar, AC; Bramlage, K; Fei, L; Ley, SL; Xanthakos, SA.
Journal of Pediatric Gastroenterology and Nutrition.
2019;
69:339-343.
Successful Management of Ketogenic Parenteral Nutrition: A Pediatric Case Study.
Lowe, H; Segal, S; Mouzaki, M; Langos, V; Dlamini, N.
Journal of Parenteral and Enteral Nutrition.
2019;
43:815-818.
Lean non-alcoholic fatty liver disease.
Wang, AY; Dhaliwal, J; Mouzaki, M.
Clinical Nutrition.
2019;
38:975-981.
Extremely low levels of low-density lipoprotein potentially suggestive of familial hypobetalipoproteinemia: A separate phenotype of NAFLD?.
Mouzaki, M; Shah, A; Arce-Clachar, AC; Hardy, J; Bramlage, K; Xanthakos, SA.
Journal of Clinical Lipidology.
2019;
13:425-431.
Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention.
Mouzaki, M; Loomba, R.
Therapeutic Advances in Gastroenterology.
2019;
12:1756284819858470-175628481985847.